StockData

Cosmos Health vs Prenetics Global

COSM and PRE side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How COSM and PRE compare

Prenetics Global grew revenue faster over the last twelve months (480% versus 33.8% for Cosmos Health).

Cosmos Health keeps more of each dollar of sales as profit, with a net margin of −33.1% compared with −40.8% at Prenetics Global.

Prenetics Global scores higher on the StockData Score (10 against 5 for Cosmos Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCOSMPRE
Size and price
Market cap$24.2M–
Share price$0.240$16.72
Change, 1 year−67.1%29.3%
Change, 5 years−93.5%−88.7%
Beta (5Y)–0.60
Employees16398
StockData Score
Total score510 (better)
Valuation score1 (better)0
Growth score22
Performance score03 (better)
Health score25 (better)
Dividend score00
Valuation
P/S0.3×–
P/B1.2×–
FCF yield−41.1%–
Fair value$0.209–
Margin of safety−14.8%–
Growth
Revenue growth (TTM)33.8%480% (better)
Revenue growth, 5Y average3.3%7.2% (better)
Profitability
Gross margin10.3%52.8% (better)
Operating margin−24.9% (better)−48.1%
Net margin−33.1% (better)−40.8%
FCF margin−13.5% (better)−23.8%
Return on equity−104%−23.1% (better)
Return on invested capital−60.9%−29.0% (better)
Financial health
Debt / equity0.06 (better)0.00
Interest coverage−7.8×–
Current ratio1.052.97 (better)
Altman Z-score−2.63–
Piotroski F-score55
Dividends and buybacks
Buyback yield−34.6%–
Shareholder yield−34.6%–
Ownership
Held by institutions2.1%–
Held by insiders17.4%14.2%
Insider net buying, 12 months$1.6M (better)$1000K
Short interest, % of float2.1%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.